Pre-asthma : a useful concept? A EUFOREA paper. Part 2—late onset eosinophilic asthma
(2024) In Frontiers in Allergy 5.- Abstract
The concept of pre-diabetes has led to provision of measures to reduce disease progression through identification of subjects at risk of diabetes. We previously considered the idea of pre-asthma in relation to allergic asthma and considered that, in addition to the need to improve population health via multiple measures, including reduction of exposure to allergens and pollutants and avoidance of obesity, there are several possible specific means to reduce asthma development in those most at risk (pre- asthma). The most obvious is allergen immunotherapy (AIT), which when given for allergic rhinitis (AR) has reasonable evidence to support asthma prevention in children (2) but also needs further study as primary prevention. In this second... (More)
The concept of pre-diabetes has led to provision of measures to reduce disease progression through identification of subjects at risk of diabetes. We previously considered the idea of pre-asthma in relation to allergic asthma and considered that, in addition to the need to improve population health via multiple measures, including reduction of exposure to allergens and pollutants and avoidance of obesity, there are several possible specific means to reduce asthma development in those most at risk (pre- asthma). The most obvious is allergen immunotherapy (AIT), which when given for allergic rhinitis (AR) has reasonable evidence to support asthma prevention in children (2) but also needs further study as primary prevention. In this second paper we explore the possibilities for similar actions in late onset eosinophilic asthma.
(Less)
- author
- organization
- publishing date
- 2024
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- chronic rhinosinusitis with nasal polyps, eosinophils, late onset asthma, mast cells, non-allergic rhinitis, S. aureus biofilm, virulence genes
- in
- Frontiers in Allergy
- volume
- 5
- article number
- 1404735
- publisher
- Frontiers Media S. A.
- external identifiers
-
- pmid:38812719
- scopus:85194724166
- ISSN
- 2673-6101
- DOI
- 10.3389/falgy.2024.1404735
- language
- English
- LU publication?
- yes
- id
- 90511561-4c7c-4e48-8bf8-ddf4cda74101
- date added to LUP
- 2024-11-06 14:52:26
- date last changed
- 2025-07-03 12:43:38
@article{90511561-4c7c-4e48-8bf8-ddf4cda74101, abstract = {{<p>The concept of pre-diabetes has led to provision of measures to reduce disease progression through identification of subjects at risk of diabetes. We previously considered the idea of pre-asthma in relation to allergic asthma and considered that, in addition to the need to improve population health via multiple measures, including reduction of exposure to allergens and pollutants and avoidance of obesity, there are several possible specific means to reduce asthma development in those most at risk (pre- asthma). The most obvious is allergen immunotherapy (AIT), which when given for allergic rhinitis (AR) has reasonable evidence to support asthma prevention in children (2) but also needs further study as primary prevention. In this second paper we explore the possibilities for similar actions in late onset eosinophilic asthma.</p>}}, author = {{Scadding, G. K. and Gray, C. and Conti, D. M. and McDonald, M. and Backer, V. and Scadding, G. and Bernal-Sprekelsen, M. and De Corso, E. and Diamant, Z. and Hopkins, C. and Jesenak, M. and Johansen, P. and Kappen, J. and Mullol, J. and Price, D. and Quirce, S. and Reitsma, S. and Toppila-Salmi, S. and Senior, B. and Thyssen, J. P. and Wahn, U. and Hellings, P. W.}}, issn = {{2673-6101}}, keywords = {{chronic rhinosinusitis with nasal polyps; eosinophils; late onset asthma; mast cells; non-allergic rhinitis; S. aureus biofilm; virulence genes}}, language = {{eng}}, publisher = {{Frontiers Media S. A.}}, series = {{Frontiers in Allergy}}, title = {{Pre-asthma : a useful concept? A EUFOREA paper. Part 2—late onset eosinophilic asthma}}, url = {{http://dx.doi.org/10.3389/falgy.2024.1404735}}, doi = {{10.3389/falgy.2024.1404735}}, volume = {{5}}, year = {{2024}}, }